Yestar Healthcare Holdings
Market Cap
HK$3.2b
Last Updated
2020/02/20 13:16 UTC
Data Sources
Company Financials +
Executive Summary
Yestar Healthcare Holdings Company Limited, an investment holding company, engages in the manufacture, distribution, and sale of medical imaging products; distribution of in vitro diagnostic products; and manufacture and sale of dental films in the People’s Republic of China.
Rewards
Risk Analysis
Snowflake Analysis
Good value with mediocre balance sheet.
Share Price & News
How has Yestar Healthcare Holdings's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 2393 has not had significant price volatility in the past 3 months.
Market Performance
7 Day Return
-2.1%
2393
0.7%
HK Medical Equipment
0.3%
HK Market
1 Year Return
-24.6%
2393
47.4%
HK Medical Equipment
-5.1%
HK Market
Return vs Industry: 2393 underperformed the Hong Kong Medical Equipment industry which returned 47.4% over the past year.
Return vs Market: 2393 underperformed the Hong Kong Market which returned -5.1% over the past year.
Shareholder returns
| 2393 | Industry | Market | |
|---|---|---|---|
| 7 Day | -2.1% | 0.7% | 0.3% |
| 30 Day | -2.8% | 2.6% | -3.9% |
| 90 Day | 0.7% | 14.4% | 4.4% |
| 1 Year | -24.6%-24.6% | 49.0%47.4% | -1.6%-5.1% |
| 3 Year | -63.0%-64.2% | 49.2%44.4% | 13.4%1.9% |
| 5 Year | -32.4%-35.8% | 43.7%35.8% | 15.6%-3.6% |
Price Volatility Vs. Market
How volatile is Yestar Healthcare Holdings's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall St
Do Directors Own Yestar Healthcare Holdings Company Limited (HKG:2393) Shares?3 weeks ago | Simply Wall St
Such Is Life: How Yestar Healthcare Holdings (HKG:2393) Shareholders Saw Their Shares Drop 63%1 month ago | Simply Wall St
Why We Like Yestar Healthcare Holdings Company Limited’s (HKG:2393) 23% Return On Capital EmployedValuation
Is Yestar Healthcare Holdings undervalued compared to its fair value and its price relative to the market?
47.7%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: 2393 (HK$1.38) is trading below our estimate of fair value (HK$2.64)
Significantly Below Fair Value: 2393 is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: 2393 is good value based on its PE Ratio (10.4x) compared to the Medical Equipment industry average (18.6x).
PE vs Market: 2393 is poor value based on its PE Ratio (10.4x) compared to the Hong Kong market (10.2x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 2393's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 2393 is good value based on its PB Ratio (2.5x) compared to the HK Medical Equipment industry average (2.5x).
Next Steps
Future Growth
How is Yestar Healthcare Holdings forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?
11.3%
Forecasted annual revenue growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 2393's forecast earnings growth is above the savings rate (1.6%).
Earnings vs Market: Insufficient data to determine if 2393's earnings are forecast to grow faster than the Hong Kong market
High Growth Earnings: Insufficient data to determine if earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 2393's revenue (11.3% per year) is forecast to grow faster than the Hong Kong market (10.5% per year).
High Growth Revenue: 2393's revenue (11.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 2393's Return on Equity is forecast to be high in 3 years time (27.4%)
Next Steps
Past Performance
How has Yestar Healthcare Holdings performed over the past 5 years?
20.7%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 2393 has high quality earnings.
Growing Profit Margin: 2393's current net profit margins (5.9%) are lower than last year (6.2%).
Past Earnings Growth Analysis
Earnings Trend: 2393's earnings have grown significantly by 20.7% per year over the past 5 years.
Accelerating Growth: 2393's earnings growth over the past year (5.4%) is below its 5-year average (20.7% per year).
Earnings vs Industry: 2393 earnings growth over the past year (5.4%) underperformed the Medical Equipment industry 43.4%.
Return on Equity
High ROE: Whilst 2393's Return on Equity (32.55%) is high, this metric is skewed due to their high level of debt.
Return on Assets
Return on Capital Employed
Next Steps
Financial Health
How is Yestar Healthcare Holdings's financial position?
Financial Position Analysis
Short Term Liabilities: 2393's short term assets (CN¥3.2B) exceed its short term liabilities (CN¥2.9B).
Long Term Liabilities: 2393's short term assets (CN¥3.2B) exceed its long term liabilities (CN¥1.8B).
Debt to Equity History and Analysis
Debt Level: 2393's debt to equity ratio (148.8%) is considered high.
Reducing Debt: 2393's debt to equity ratio has increased from 22.7% to 148.8% over the past 5 years.
Debt Coverage: 2393's debt is not well covered by operating cash flow (19.2%).
Interest Coverage: 2393's interest payments on its debt are well covered by EBIT (5.6x coverage).
Balance Sheet
Inventory Level: 2393 has a low level of unsold assets or inventory.
Debt Coverage by Assets: 2393's debt is covered by short term assets (assets are 1.8x debt).
Next Steps
Dividend
What is Yestar Healthcare Holdings's current dividend yield, its reliability and sustainability?
5.44%
Forecast Dividend Yield
Dividend Yield vs Market
Current dividend yield vs market & industry
Notable Dividend: Unable to evaluate 2393's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate 2393's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if 2393's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 2393's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: 2393 is not paying a notable dividend for the Hong Kong market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of 2393's dividend in 3 years as they are not forecast to pay a notable one for the Hong Kong market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
4.5yrs
Average management tenure
CEO
James Hartono (43yo)
CN¥4,372,000
Compensation
Mr. James Hartono serves as the Chairman of The Board and Chief Executive Officer of Yestar International Holdings Company Limited. Mr. Hartono has over 12 years of experience in the distribution of image ...
CEO Compensation Analysis
Compensation vs Market: James's total compensation ($USD624.75K) is above average for companies of similar size in the Hong Kong market ($USD350.06K).
Compensation vs Earnings: James's compensation has been consistent with company performance over the past year.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 0yrs | CN¥4.37m | 26.1% CN¥847.6m | |
| CFO & Executive Director | 8yrs | CN¥988.00k | no data | |
| COO & Executive Director | 4.1yrs | CN¥2.28m | no data | |
| Executive Director | 7yrs | CN¥2.00m | no data | |
| Company Secretary | 4.8yrs | no data | no data | |
| GM of Yestar Technology | 0yrs | no data | no data | |
| Chief Executive Officer of Shanghai Emphasis Investment Management Consulting Co Ltd | 4.5yrs | no data | 6.95% CN¥225.5m |
4.5yrs
Average Tenure
44yo
Average Age
Experienced Management: 2393's management team is considered experienced (4.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 0yrs | CN¥4.37m | 26.1% CN¥847.6m | |
| CFO & Executive Director | 8yrs | CN¥988.00k | no data | |
| COO & Executive Director | 4.1yrs | CN¥2.28m | no data | |
| Executive Director | 7yrs | CN¥2.00m | no data | |
| Independent Non-Executive Director | 6.4yrs | CN¥204.00k | no data | |
| Independent Non-Executive Director | 6.4yrs | CN¥204.00k | no data | |
| Independent Non-Executive Director | 6.4yrs | CN¥204.00k | no data |
6.4yrs
Average Tenure
44yo
Average Age
Experienced Board: 2393's board of directors are considered experienced (6.4 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 5.6%.
Top Shareholders
Company Information
Yestar Healthcare Holdings Company Limited's company bio, employee growth, exchange listings and data sources
Key Information
- Name: Yestar Healthcare Holdings Company Limited
- Ticker: 2393
- Exchange: SEHK
- Founded: 1971
- Industry: Health Care Supplies
- Sector: Healthcare
- Market Cap: HK$3.247b
- Shares outstanding: 2.37b
- Website: https://www.yestarcorp.com
Number of Employees
Location
- Yestar Healthcare Holdings Company Limited
- Green Land Building
- Floor 8, Block A
- Shanghai
- 201199
- China
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| 2393 | SEHK (The Stock Exchange of Hong Kong Ltd.) | Yes | Ordinary Shares | HK | HKD | Oct 2013 |
| YSHC.F | OTCPK (Pink Sheets LLC) | Yes | Ordinary Shares | US | USD | Oct 2013 |
Biography
Yestar Healthcare Holdings Company Limited, an investment holding company, engages in the manufacture, distribution, and sale of medical imaging products; distribution of in vitro diagnostic products; and manufacture and sale of dental films in the People’s Republic of China. It operates in two segments, Imaging Printing Products, and Medical Products and Equipment. The Imaging Printing Products segment manufactures and sells Fujifilm color photographic paper, industrial NDT X-ray films, and PWB films; and trades in imaging equipment. Its products are used in professional and minilabs; and industrial imaging applications. This segment provides NDT X-ray films under the Yes!Star brand. The Medical Products and Equipment segment offers medical dry and wet films, and dental films; and sells medical equipment and diagnostic reagents. Yestar Healthcare Holdings Company Limited also engages in the biotechnology development activities. The company was formerly known as Yestar International Holdings Company Limited and changed its name to Yestar Healthcare Holdings Company Limited in January 2017. Yestar Healthcare Holdings Company Limited was founded in 1971 and is headquartered in Shanghai, the People’s Republic of China.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2020/02/20 13:16 |
| End of Day Share Price | 2020/02/20 00:00 |
| Earnings | 2019/06/30 |
| Annual Earnings | 2018/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.